These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 17391289)
1. Cell cycle arrest by oxaliplatin on cancer cells. William-Faltaos S; Rouillard D; Lechat P; Bastian G Fundam Clin Pharmacol; 2007 Apr; 21(2):165-72. PubMed ID: 17391289 [TBL] [Abstract][Full Text] [Related]
2. Cell cycle arrest and apoptosis induced by oxaliplatin (L-OHP) on four human cancer cell lines. William-Faltaos S; Rouillard D; Lechat P; Bastian G Anticancer Res; 2006; 26(3A):2093-9. PubMed ID: 16827150 [TBL] [Abstract][Full Text] [Related]
3. Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines. Atallah D; Marsaud V; Radanyi C; Kornprobst M; Rouzier R; Elias D; Renoir JM Int J Hyperthermia; 2004 Jun; 20(4):405-19. PubMed ID: 15204521 [TBL] [Abstract][Full Text] [Related]
4. In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines. Qin B; Tanaka R; Shibata Y; Arita S; Ariyama H; Kusaba H; Baba E; Harada M; Nakano S Anticancer Drugs; 2006 Apr; 17(4):445-53. PubMed ID: 16550003 [TBL] [Abstract][Full Text] [Related]
5. Exposure-response relationships for oxaliplatin-treated colon cancer cells. Kirstein MN; Root SA; Moore MM; Wieman KM; Williams BW; Jacobson PA; Marker PH; Tuttle TM Anticancer Drugs; 2008 Jan; 19(1):37-44. PubMed ID: 18043128 [TBL] [Abstract][Full Text] [Related]
6. In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines. Tanaka R; Ariyama H; Qin B; Takii Y; Baba E; Mitsugi K; Harada M; Nakano S Cancer Chemother Pharmacol; 2005 Jun; 55(6):595-601. PubMed ID: 15731917 [TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer. Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380 [TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers. Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752 [TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines. Noordhuis P; Laan AC; van de Born K; Losekoot N; Kathmann I; Peters GJ Biochem Pharmacol; 2008 Jul; 76(1):53-61. PubMed ID: 18508032 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of G1/S transition potentiates oxaliplatin-induced cell death in colon cancer cell lines. Rakitina TV; Vasilevskaya IA; O'Dwyer PJ Biochem Pharmacol; 2007 Jun; 73(11):1715-26. PubMed ID: 17343830 [TBL] [Abstract][Full Text] [Related]
11. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro. Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892 [TBL] [Abstract][Full Text] [Related]
12. Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells. Chiu SJ; Hsu TS; Chao JI Toxicol Lett; 2006 Dec; 167(2):122-30. PubMed ID: 17045763 [TBL] [Abstract][Full Text] [Related]
13. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells. Somers-Edgar TJ; Rosengren RJ Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129 [TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. Lin MS; Chen WC; Bai X; Wang YD J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820 [TBL] [Abstract][Full Text] [Related]
15. LA-12 overcomes confluence-dependent resistance of HT-29 colon cancer cells to Pt (II) compounds. Svihálková-Sindlerová L; Foltinová V; Vaculová A; Horváth V; Soucek K; Sova P; Hofmanová J; Kozubík A Anticancer Res; 2010 Apr; 30(4):1183-8. PubMed ID: 20530425 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells. Temmink OH; Hoebe EK; van der Born K; Ackland SP; Fukushima M; Peters GJ Br J Cancer; 2007 Jan; 96(2):231-40. PubMed ID: 17242697 [TBL] [Abstract][Full Text] [Related]
17. Effect of glutathione combined with cisplatin and oxaliplatin on the proliferation and apoptosis of lung carcinoma cell line. Xu Y; Jiang N; Yu H Toxicol Mech Methods; 2010 Oct; 20(8):487-92. PubMed ID: 20843266 [TBL] [Abstract][Full Text] [Related]
18. Influence of a novel platinum compound--cis-dichloro (dimethylsulphoxide) (1-beta-D-rybofuranosyl-1,2,4-triazolo-3-arboxyamide) platinum (II)--"Pt-rib-1"--on cell cycle and apoptosis in ClS91 and B16 mouse melanoma in vitro. Drewa T; Olszewska-Słonina D; Woźniak A; Styczyński J; Drewa G; Szłyk E; Lakomska I; Kobe J; Czajkowski R Acta Pol Pharm; 2004; 61(1):39-44. PubMed ID: 15259856 [TBL] [Abstract][Full Text] [Related]
19. Different cell cycle kinetic effects of N1,N11-diethylnorspermine-induced polyamine depletion in four human breast cancer cell lines. Myhre L; Alm K; Hegardt C; Staaf J; Jönsson G; Larsson S; Oredsson SM Anticancer Drugs; 2008 Apr; 19(4):359-68. PubMed ID: 18454046 [TBL] [Abstract][Full Text] [Related]